Revista de gastroenterologia de Mexico (English) · 2025
Genetic predisposition to celiac disease in persons with Down syndrome in Northwestern Mexico.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ávalos-Camacho C, Esparza-Ocampo K, Gastelum-Espinoza W, Guadrón-Llanos A, Aguayo-Patrón S V, Picos-Cárdenas V, Calderón Zamora L, Duarte de la Peña G, Calderón de la Barca A M, Magaña-Gómez J
Аннотация
INTRODUCTION AND AIM: Celiac disease (CD) is an autoimmune enteropathy triggered by ingested gluten, with intra- and extra-gastrointestinal symptoms. Individuals with Down syndrome (DS) have a higher prevalence of autoimmune disorders, including CD. This study aimed to evaluate genetic predisposition (HLA haplotypes) and serological markers of CD in individuals with DS, from Northwestern Mexico.
METHODS: Eighty-six participants with DS, 3-64 years of age, were included in the study. We assessed HLA-DQ2 and DQ8 haplotypes by duplex PCR and related symptoms, as well as IgG and IgA anti-gliadin antibodies, and IgA anti-tissue transglutaminase antibodies by an enzymatic immunoassay.
RESULTS: Most participants (98.8%) carried risk alleles, with 52.9% having HLA-DQ2 and 45.9% HLA-DQ8. IgG anti-gliadin antibodies were positive in 8.1% of participants. In comparison, 6.9% were positive for IgA anti-gliadin antibodies, and 9.3% had a positive index for IgA anti-tissue transglutaminase antibodies. Four participants (4.6%) presented full or partial HLA-DQ2/DQ8 haplotypes, positive indexes for IgA anti-gliadin, and anti-transglutaminase antibodies related to CD.
CONCLUSIONS: The study reveals an almost complete genetic predisposition to autoimmunity and a very high risk of CD in individuals with DS. Enhanced diagnostic protocols and ongoing monitoring are recommended to improve the management of CD in this vulnerable population.
METHODS: Eighty-six participants with DS, 3-64 years of age, were included in the study. We assessed HLA-DQ2 and DQ8 haplotypes by duplex PCR and related symptoms, as well as IgG and IgA anti-gliadin antibodies, and IgA anti-tissue transglutaminase antibodies by an enzymatic immunoassay.
RESULTS: Most participants (98.8%) carried risk alleles, with 52.9% having HLA-DQ2 and 45.9% HLA-DQ8. IgG anti-gliadin antibodies were positive in 8.1% of participants. In comparison, 6.9% were positive for IgA anti-gliadin antibodies, and 9.3% had a positive index for IgA anti-tissue transglutaminase antibodies. Four participants (4.6%) presented full or partial HLA-DQ2/DQ8 haplotypes, positive indexes for IgA anti-gliadin, and anti-transglutaminase antibodies related to CD.
CONCLUSIONS: The study reveals an almost complete genetic predisposition to autoimmunity and a very high risk of CD in individuals with DS. Enhanced diagnostic protocols and ongoing monitoring are recommended to improve the management of CD in this vulnerable population.